{"id":845544,"date":"2025-05-01T16:19:36","date_gmt":"2025-05-01T20:19:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/"},"modified":"2025-05-01T16:19:36","modified_gmt":"2025-05-01T20:19:36","slug":"genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/","title":{"rendered":"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference"},"content":{"rendered":"
\n

WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Genelux Corporation<\/a> (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick<\/a>, President, CEO and Chairman of the Board, and Matt Pulisic<\/a>, CFO, will discuss clinical-stage programs and upcoming milestones in a fireside chat at the Citizens Life Sciences Conference taking place May 7-8, 2025, in New York.<\/p>\n

The conversation with\u00a0Biotech Equity Research Managing Director, Silvan Tuerkcan, PhD, is scheduled to begin at\u00a01:30 p.m. ET on Thursday, May 8, 2025. A webcast link for the event will be available at https:\/\/wsw.com\/webcast\/jmp65\/gnlx\/1693890<\/strong><\/a>. An archived replay will be available for approximately 90 days following the event on the company\u2019s IR page.<\/p>\n

The Company will also attend one-on-one meetings during the conference. Institutional investors interested in arranging a meeting with Genelux management can register to attend the conference or contact genelux@allelecomms.com.<\/p>\n

\n About Genelux Corporation<\/strong>
\n
Genelux\u00a0is a late clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and\/or difficult-to-treat solid tumor types. Olvi-Vec currently is being evaluated in two\u00a0U.S.-based clinical trials: OnPrime\/GOG-3076, a multi-center, randomized, open-label Phase 3 registrational trial evaluating the efficacy and safety of Olvi-Vec in combination platinum-doublet + bevacizumab compared with physician’s choice of chemotherapy and bevacizumab in patients with platinum-resistant\/refractory ovarian cancer; and, VIRO-25, a multi-center, randomized, open-label Phase 2 trial evaluating the efficacy and safety of Olvi-Vec & Platinum-doublet + physician’s choice of immune checkpoint inhibitor compared to docetaxel in non-small-cell lung cancer. Additionally, Olvi-Vec currently is being evaluated for dose selection in Olvi-Vec-SCLC-202, a\u00a0China-based, multi-center, open label Ph1b evaluating the efficacy and safety of Olvi-Vec & Platinum-doublet in recurrent small-cell lung cancer.\u00a0 The core of\u00a0Genelux’s\u00a0discovery and development efforts revolves around its\u2019 proprietary CHOICE\u2122 platform from which the Company has developed an extensive library of isolated and engineered oncolytic vaccinia virus immunotherapeutic product candidates, including Olvi-Vec. For more information, please visit www.genelux.com<\/a> and follow us on Twitter @Genelux_Corp<\/a> and on LinkedIn<\/a>.<\/p>\n

\n Investor and Media Contacts<\/strong>\n <\/p>\n

Ankit Bhargava, MD
Allele Communications, LLC
genelux@allelecomms.com<\/p>\n

Source: Genelux Corporation<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, and Matt Pulisic, CFO, will discuss clinical-stage programs and upcoming milestones in a fireside chat at the Citizens Life Sciences Conference taking place May 7-8, 2025, in New York. The conversation with\u00a0Biotech Equity Research Managing Director, Silvan Tuerkcan, PhD, is scheduled to begin at\u00a01:30 p.m. ET on Thursday, May 8, 2025. A webcast link for the event will be available at https:\/\/wsw.com\/webcast\/jmp65\/gnlx\/1693890. An archived replay will be available for approximately 90 days following the event on the company\u2019s IR page. The Company will also attend one-on-one meetings during the conference. … <\/p>\n

Continue reading “Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-845544","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGenelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, and Matt Pulisic, CFO, will discuss clinical-stage programs and upcoming milestones in a fireside chat at the Citizens Life Sciences Conference taking place May 7-8, 2025, in New York. The conversation with\u00a0Biotech Equity Research Managing Director, Silvan Tuerkcan, PhD, is scheduled to begin at\u00a01:30 p.m. ET on Thursday, May 8, 2025. A webcast link for the event will be available at https:\/\/wsw.com\/webcast\/jmp65\/gnlx\/1693890. An archived replay will be available for approximately 90 days following the event on the company\u2019s IR page. The Company will also attend one-on-one meetings during the conference. … Continue reading "Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-01T20:19:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0Mjk4OSM2OTE2ODA2IzIyNDkwNTQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference\",\"datePublished\":\"2025-05-01T20:19:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/\"},\"wordCount\":363,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0Mjk4OSM2OTE2ODA2IzIyNDkwNTQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/\",\"name\":\"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0Mjk4OSM2OTE2ODA2IzIyNDkwNTQ=\",\"datePublished\":\"2025-05-01T20:19:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0Mjk4OSM2OTE2ODA2IzIyNDkwNTQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0Mjk4OSM2OTE2ODA2IzIyNDkwNTQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/","og_locale":"en_US","og_type":"article","og_title":"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference - Market Newsdesk","og_description":"WESTLAKE VILLAGE, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman of the Board, and Matt Pulisic, CFO, will discuss clinical-stage programs and upcoming milestones in a fireside chat at the Citizens Life Sciences Conference taking place May 7-8, 2025, in New York. The conversation with\u00a0Biotech Equity Research Managing Director, Silvan Tuerkcan, PhD, is scheduled to begin at\u00a01:30 p.m. ET on Thursday, May 8, 2025. A webcast link for the event will be available at https:\/\/wsw.com\/webcast\/jmp65\/gnlx\/1693890. An archived replay will be available for approximately 90 days following the event on the company\u2019s IR page. The Company will also attend one-on-one meetings during the conference. … Continue reading \"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-01T20:19:36+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0Mjk4OSM2OTE2ODA2IzIyNDkwNTQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference","datePublished":"2025-05-01T20:19:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/"},"wordCount":363,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0Mjk4OSM2OTE2ODA2IzIyNDkwNTQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/","name":"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0Mjk4OSM2OTE2ODA2IzIyNDkwNTQ=","datePublished":"2025-05-01T20:19:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0Mjk4OSM2OTE2ODA2IzIyNDkwNTQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0Mjk4OSM2OTE2ODA2IzIyNDkwNTQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genelux-corporation-to-participate-in-a-fireside-chat-at-the-citizens-life-sciences-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/845544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=845544"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/845544\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=845544"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=845544"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=845544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}